Analyst Ratings for Meridian Biosciences (VIVO)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2022 | H.C. Wainwright | Yi Chen | Downgrade | Neutral (Buy) |
34.00 (30.00) |
33.27 (33.97) |
2.1% | Details |
| 8/11/2020 | Piper Sandler » Updated 2/8/2021 |
Steven Mah | New Coverage | Overweight (N/A) |
34.00 (26.00) |
19.32 (33.97) |
75.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
